Neonatal autonomic regulation as a predictor of autism symptoms in very preterm infants.
Neonatal autonomic regulation as a predictor of autism symptoms in very preterm infants.
复制标题
新生儿自主调节作为极早产儿自闭症症状的预测因子。
DOI:
10.1038/s41372-024-01942-2
复制
发表时间:
2024
期刊:
影响因子:
--
通讯作者:
Dail,RobinB
中科院分区:
文献类型:
--
作者:
Bradshaw,Jessica;O'Reilly,Christian;Everhart,KaylaC;Dixon,Elizabeth;Vinyard,Amy;Tavakoli,Abbas;Dail,RobinB
MethodsA subset of VPT infants from a large, multisite clinical trial [3] were enrolled in this study at birth (N= 20). Given previous studies linking ASD to abnormal HRCs and to provide a multimodal measurement of ANS dysfunction, continuous measures of minute-by-minute TGs, defined by the difference between central and peripheral temperatures [3], and hour-by-hour abnormal heart rate characteristics (HRCs), measured using HeRO scores [4], were collected from birth-28 days (> 40,000 samples/infant). HeRO scores are generated by a HeRO monitor (Medical Predictive Science Corp), calculated from a proprietary algorithm that considers abnormality of three HRCs: standard deviation of inter-beat intervals, heart rate skewness or asymmetry, and entropy (see Supplementary Information). ANS dysfunction is indicated by abnormal HRCs (HeRO scores> 1) or elevated negative TGs (peripheral> central body temperature)[5]. Following NICU discharge, standardized measures of cognition, language, and motor skills were collected at corrected ages 6, 9, and 12 months (see Supplementary Information). At 12 months, assessments of social communication and direct observation of early ASD symptoms (Systematic Observation of Red Flags; SORF) were administered [6, 7, 8](see Supplementary Information). The SORF has been used with infants (9–24 months) with complex developmental and ASD profiles. Informed consent was completed with the mother prior to any study procedures, which were approved by hospital and university institutional review boards. Univariate, multivariate, and robust regression models were used to evaluate neonatal predictors of ASD outcomes.ResultsDescriptive statistics for all measures are presented in Table 1 and Supplementary Fig. S 1. Continuous measures of ANS function were collected for N= 20 infants enrolled at birth. Following NICU discharge, n= 12 completed 1-year developmental follow-up (10 males) and n= 1 was excluded from analyses due to significant medical morbidities that precluded a valid ASD assessment (see Supplementary Fig. S 1). Across all infants in the first 28 days of life, the average HeRO score was just above 1 and infants experienced abnormal negative TGs for about 20% of the time (6 of 28 days). In terms of developmental trajectories, significant delays did not emerge until 12 months when over 50% of the sample exhibited social-communication delays and exceeded the clinical cutoff for ASD risk (see Supplementary Table S 1 and Supplementary Fig S 2). Neonatal abnormal HRCs were strongly associated with ASD symptoms at 12 months (r= 0.81, p< 0.01; Fig. 1), as was birth gestational age (GA), birth weight (BW), and abnormal negative TGs. A regression model including GA, BW, and abnormal HRCs revealed a significant, unique predictive effect of abnormal HRCs on ASD outcomes (model r= 0.86, p= 0.017; HRC r= 0.72, p= 0.029).